Variable | Pre-reform | Post-reform | χ2/Z | P value |
---|---|---|---|---|
Sex, n (%) | 0.97 | 0.320 | ||
Male | 2346 (57.9) | 5172 (57.0) | ||
Female | 1707 (42.1) | 3908 (43.0) | ||
Age (years), n (%) | 4.83 | 0.089 | ||
<1 | 2635 (65.0) | 5775 (63.6) | ||
1–5 | 1345 (33.2) | 3096 (34.1) | ||
6–14 | 73 (1.8) | 209 (2.3) | ||
Length of stay (days), n (%) | 258.27 | < 0.001 | ||
<4 | 119 (2.9) | 201 (2.2) | ||
4–7 | 2147 (53.0) | 6063 (66.8) | ||
8–14 | 1663 (41.0) | 2716 (29.9) | ||
>14 | 124 (3.1) | 100 (1.1) | ||
Transferred to the ICU, n (%) | 142 (3.5) | 420 (4.6) | 0.503 | 0.478 |
Discharge outcome, n (%) | 53.49 | < 0.001 | ||
Cured | 3502 (87.0) | 8219 (90.6) | ||
Improved | 495 (12.3) | 823 (9.1) | ||
Not cured | 11 (0.3) | 19 (0.2) | ||
Others | 17 (0.4) | 6 (0.1) | ||
Total cost, M (Q1, Q3) | 4150.7 (3083.9, 7081.9) | 3853.3 (3017.1, 5217.5) | -11.46 | < 0.001 |
Comprehensive medical service cost, M (Q1, Q3) | 1676.4 (1199.7, 3902.1) | 1572.5 (1163.8, 2316.0) | -12.18 | < 0.001 |
Diagnostic cost, M (Q1, Q3) | 932.9 (676.1, 1490.0) | 1143.6 (858.5, 1559.6) | 17.41 | < 0.001 |
Medication cost, M (Q1, Q3) | 1137.2 (815.6, 1576.9) | 876.1 (602.9, 1239.3) | -25.74 | < 0.001 |
Material cost, M (Q1, Q3) | 120.3 (67.5, 256.7) | 126.8 (45.6, 195.4) | -12.11 | < 0.001 |
Other cost, M (Q1, Q3) | 0.0 (0.0, 311.4) | 0.0 (0.0, 0.0) | -22.68 | < 0.001 |
Medication cost ratio, mean (SD) | 0.27 (0.12) | 0.23 (0.09) | 19.12 | < 0.001 |
Antibiotic cost ratio, mean (SD) | 0.53 (0.04) | 0.52 (0.05) | 8.66 | < 0.001 |